The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

by | Jul 4, 2025 | Publications

Leukemia. 2025 Jul 2. doi: 10.1038/s41375-025-02677-5. Online ahead of print. ABSTRACT The cytogenetic abnormalities translocations t(4;14) and t(14;16) and the deletion of chromosome 17p in newly-diagnosed multiple myeloma are associated with poor disease prognosis...